Elevated APOC2 levels have also been found in the CSF of progressive MS subtypes in comparison with relapsing subtypes and have been associated with enhanced inflammation and elevated markers like IL-2 and IL-16 and eotaxin-3/CCL26 [26]. This evidence concerns the gene IL2 and myeloid sarcoma.